Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 180

1.

The blockade of immune checkpoints in cancer immunotherapy.

Pardoll DM.

Nat Rev Cancer. 2012 Mar 22;12(4):252-64. doi: 10.1038/nrc3239. Review.

PMID:
22437870
[PubMed - indexed for MEDLINE]
2.

Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.

Peggs KS, Quezada SA, Allison JP.

Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x. Review.

PMID:
18759925
[PubMed - indexed for MEDLINE]
3.

Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.

Emens LA.

Expert Rev Anticancer Ther. 2012 Dec;12(12):1597-611. doi: 10.1586/era.12.147. Review.

PMID:
23253225
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade.

Weber J.

Semin Oncol. 2010 Oct;37(5):430-9. doi: 10.1053/j.seminoncol.2010.09.005. Review.

PMID:
21074057
[PubMed - indexed for MEDLINE]
5.

Immunotherapeutics for breast cancer.

Criscitiello C, Curigliano G.

Curr Opin Oncol. 2013 Nov;25(6):602-8. doi: 10.1097/CCO.0000000000000020. Review.

PMID:
24076578
[PubMed - indexed for MEDLINE]
6.

Immune checkpoint blockade immunotherapy to activate anti-tumour T-cell immunity.

Ramsay AG.

Br J Haematol. 2013 Aug;162(3):313-25. doi: 10.1111/bjh.12380. Epub 2013 May 21. Review.

PMID:
23691926
[PubMed - indexed for MEDLINE]
7.

[Immune-checkpoints: the new anti-cancer immunotherapies].

Ileana E, Champiat S, Soria JC.

Bull Cancer. 2013 Jun;100(6):601-10. doi: 10.1684/bdc.2013.1771. Review. French.

PMID:
23735730
[PubMed - indexed for MEDLINE]
8.

Combination immunotherapy approaches.

Drake CG.

Ann Oncol. 2012 Sep;23 Suppl 8:viii41-6. doi: 10.1093/annonc/mds262. Review.

PMID:
22918927
[PubMed - indexed for MEDLINE]
Free Article
9.

Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.

Bendle GM, Holler A, Downs AM, Xue SA, Stauss HJ.

Expert Opin Biol Ther. 2005 Sep;5(9):1183-92. Review.

PMID:
16120049
[PubMed - indexed for MEDLINE]
10.

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

Finn OJ.

Ann Oncol. 2012 Sep;23 Suppl 8:viii6-9. doi: 10.1093/annonc/mds256. Review.

PMID:
22918931
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].

Alfaro C, Murillo O, Tirapu I, Azpilicueta A, Huarte E, Arina A, Arribillaga L, Pérez-Gracia JL, Bendandi M, Prieto J, Lasarte JJ, Melero I.

An Sist Sanit Navar. 2006 Jan-Apr;29(1):77-96. Review. Spanish.

PMID:
16670731
[PubMed - indexed for MEDLINE]
Free Article
12.

Checkpoint blockade in cancer immunotherapy.

Korman AJ, Peggs KS, Allison JP.

Adv Immunol. 2006;90:297-339. Review.

PMID:
16730267
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Knutson KL, Disis ML.

Cancer Immunol Immunother. 2005 Aug;54(8):721-8. Epub 2005 Jan 27. Review.

PMID:
16010587
[PubMed - indexed for MEDLINE]
14.

Prostate cancer: advances in immunotherapy.

Hurwitz AA, Yanover P, Markowitz M, Allison JP, Kwon ED.

BioDrugs. 2003;17(2):131-8. Review.

PMID:
12641491
[PubMed - indexed for MEDLINE]
15.

Checkpoint blocking antibodies in cancer immunotherapy.

Kyi C, Postow MA.

FEBS Lett. 2014 Jan 21;588(2):368-76. doi: 10.1016/j.febslet.2013.10.015. Epub 2013 Oct 23. Review.

PMID:
24161671
[PubMed - indexed for MEDLINE]
16.

TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.

Conroy H, Marshall NA, Mills KH.

Oncogene. 2008 Jan 7;27(2):168-80. doi: 10.1038/sj.onc.1210910. Review.

PMID:
18176598
[PubMed - indexed for MEDLINE]
17.

Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies.

Korman A, Yellin M, Keler T.

Curr Opin Investig Drugs. 2005 Jun;6(6):582-91. Review.

PMID:
15988909
[PubMed - indexed for MEDLINE]
18.

Specific immunotherapy of cancer in elderly patients.

Matzku S, Zöller M.

Drugs Aging. 2001;18(9):639-64. Review.

PMID:
11599633
[PubMed - indexed for MEDLINE]
19.

Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.

Jäger D, Jäger E, Knuth A.

J Clin Pathol. 2001 Sep;54(9):669-74. Review.

PMID:
11533070
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[Immunotherapy: new insights].

Geissler M, Weth R.

Praxis (Bern 1994). 2002 Dec 18;91(51-52):2236-46. Review. German.

PMID:
12564040
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk